Psychopathology and Psychosocial Adjustment in Patients with HIV-associated Lipodystrophy
Overview
Authors
Affiliations
Objective: To study whether patients with HIV-1 associated lipodystrophy (LD) on highly active antiretroviral treatment (HAART) have more psychopathology and worse psychosocial adjustment than a similar group without this syndrome.
Methods: In a cross-sectional, observational study we compared 47 HIV-1 infected patients with LD (LD group) with 39 HIV-1 infected patients without LD (non-LD group). All participants were on HAART. The Beck Depression Inventory (BDI), the State and Trait Anxiety Inventory (STAI) and the Goldberg Health Questionnaire (GHQ-60) were administered. Levels of familial, work and social adjustment and adjustment to stressful events were evaluated in a semi-structured interview. Clinical information was extracted from the clinical records.
Results: In the univariate analysis patients with LD showed higher state anxiety scores (p=0.009) and worse work adjustment (p=0.019) than those without LD. A total of 45.3% of LD patients scored above the cut-off point on the trait anxiety scale, and over 33.3% scored above the cut-off point on the BDI, GHQ and state anxiety scales. However, in multivariate analyses LD was not independently associated with psychopathology or with worse adjustment in the studied areas.
Conclusions: The finding that LD was not a predictor of greater psychopathology or worse psychosocial adjustment in HIV-1 infected patients, despite the high scores found, suggests that factors not taken into account in this study, such as LD severity and self-perception should have been included in the analysis. Further studies including a greater number of variables and a larger sample size will advance our understanding of this complex condition.
Park K, Hwang S, Choi B, Kim J, Kim S, Kim W Epidemiol Health. 2021; 43:e2021002.
PMID: 33445826 PMC: 7952836. DOI: 10.4178/epih.e2021002.
Verolet C, Delhumeau-Cartier C, Sartori M, Toma S, Zawadynski S, Becker M AIDS Res Ther. 2015; 12:21.
PMID: 26097493 PMC: 4475332. DOI: 10.1186/s12981-015-0061-z.